eDruginfo.com
Wolters Kluwer | Lippincott Williams & Wilkins
Drug Warnings

   Drug Updates

   Patient Teaching

   Drug Warnings

   News Capsules

   Herbal Spotlight

   Quik Tools

   Drug Info Links

   Drug Info Bookstore

   Feedback

   Disclaimer



dextroamphetamine and amphetamine
Generic only: dextroamphetamine and amphetamine
  Pharmaceutical company:
Barr Laboratories
www.barrlabs.com

NEW WARNING
Barr Laboratories issued a voluntary recall of dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate 20-mg tablets, supplied in 100-count bottles with the lot number 311756. The product is being recalled because the affected lot may contain some tablets that exceed weight requirements, which may lead to super-potent tablets. Adverse effects of a higher-than-normal dose may include palpitations, tachycardia, hypertension, headache, tremor, tic, dyskinesia, dizziness, blurred vision, sweating, insomnia, agitation, euphoria, mania, anxiety, restlessness, nausea, diarrhea, constipation, dry mouth, and decreased appetite.
   This product can be identified as an oval peach colored tablet, debossed with b/973 on one side and 2/0 on the other side. The affected lot was distributed between 6/11/09 and 6/16/09. Customers who have this lot should stop using the product immediately and return it to their pharmacy or distributer. Contact Barr Laboratories at 888-742-5578 from 8:00 AM to 8:00 PM EDT Monday through Friday for questions. Report any adverse reactions to the Food and Drug Administration's MedWatch Adverse Event Reporting Program either online, by phone at 1-800-FDA-1088, by fax at 1-800-FDA-0178, or by mail at MedWatch 5600 Fishers Lane Rockville, MD 20852-9787.

     
   

Home - Guest Registry - Customer Service

Brought to you by Lippincott Williams & Wilkins.
For help on how you should use this site, see our
Disclaimer .

© Copyright 2010 by Lippincott Williams & Wilkins